Palmetto Genomic Testing Cooperative's Hematologic Neoplasms, Solid Tumor Tests Receive NY State Approval, Medicare Coverage The next-generation sequencing-based tests can be performed on small samples, including needle aspiration samples, and use artificial intelligence software. Veracyte Bladder Cancer Test Receives Medicare Coverage The patient must be a candidate for multiple potential treatments with varying levels of intensity or multiple therapies. Palmetto Releases Draft LCD for Prostate Cancer Risk Stratification Tests Under the local coverage determination, tests to help identify patients who may benefit from a prostate biopsy would be covered under certain conditions. Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection Under the policy, covered tests must provide information about active rejection status or cellular or antibody-mediated rejection status. Local Coverage Determinations Roundup: Castle Bio A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors. Nov 19, 2020 CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests Nov 6, 2020 Medicare Administrative Contractor CGS Aligns Coverage for Melanoma Risk Stratification Tests Nov 2, 2020 GenomeWeb Index Up 5 Percent in October as Favorable Earnings Reports Bolster Shaky Market Oct 28, 2020 Strata Oncology Receives Medicare Coverage for NGS Test Oct 22, 2020 Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences Oct 8, 2020 Castle Bio Receives Expanded Medicare Coverage for Melanoma Test Oct 1, 2020 CareDx Shares Spike as AlloSure Heart Transplant Test Garners Final LCD From Palmetto Sep 25, 2020 Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test Sep 25, 2020 Natera Cancer Liquid Biopsy Test Coverage to Expand Under New Draft LCD Sep 10, 2020 Two Medicare Contractors Align Coverage for MRD Testing With Palmetto Sep 3, 2020 Natera Receives LCD From Palmetto for Signatera MRD Test in Colorectal Cancer Patients Jul 28, 2020 NeoGenomics Expects Q3 Revenue Growth as it Expands Liquid Biopsy Offerings, COVID-19 Testing Premium Jul 2, 2020 Noridian Aligns With Palmetto on Single-Gene, Multi-Gene PGx Test Coverage Jun 19, 2020 Local Coverage Determinations Roundup: Razor Genomics, Guardant Health Jun 11, 2020 Palmetto Providing Limited Coverage for Single-Gene, Multi-Gene PGx Tests May 26, 2020 NeoGenomics, Inivata Partner to Commercialize Lung Cancer Liquid Biopsy Test Apr 30, 2020 Oncocyte NSCLC Test Gets Local Coverage Determination From Palmetto Mar 12, 2020 Noridian Issues Final LCD for Decipher Biosciences Prostate Cancer Test Feb 28, 2020 Local Coverage Determinations Roundup: Natera, DermTech Jan 30, 2020 MolDx Finalizes Expanded Coverage for Liquid Biopsies Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.